Artivila Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2018

Location

Shenzhen Guangdong China

Primary Industry

Pharmaceuticals

About

Established in 2018 and based in Shenzhen, China, Artivila is a biotechnology company that engages in the research and development of drugs for neuro-degenerative diseases, cancers and autoimmune diseases through AI powered drug discovery engine. The founder of the company, Dr. Mike Zhu, received a doctor degree from University of Fribourg and was the principal Investigator at Celgene, the principal Investigator at Avila Therapeutics and the principal Scientist at Pfizer. Dr. Mike Zhu has more than 19 years of drug discovery experience, especially in the fields of data analysis, AI / ML approach, drug design, cheminformatics and computational chemistry. The co-founder of the company, Dr. David Niu, finished a doctor degree from New York University and was the vice president at Silicon Therapeutics and the director of Chemistry at Celgene. Dr. David Niu participated in over 10 projects that advanced into clinical stages, which includes the 3rd generation EGFR inhibitor, an HCV drug, and several clinical candidates in Celgene. The company's main business is an AI-driven R&D platform eLead, it enables developers to targets search, targets validation, lead discovery and optimization, candidates selection, IND enabling and clinical trials. Besides, the company focuses on the development of drugs for neurodegenerative diseases, autoimmune diseases and oncology. The company plans to use the pre series A+ funding to new drug development AI platform construction, pipeline advancement and expansion, and corporate operations and international business expansion.

Current Investors

HighLight Capital, MED-FINE Capital, Yijing Investment

Request a demo to show more

Primary Industry

Pharmaceuticals

Sub Industries

Biopharmaceuticals, Pharmaceutical Research & Development

Website

www.artivila.com

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.